In line with her upbeat outlook on the cosibelimab potential, kim rates ckpt shares an overweight (i.e., buy), and her $16 price target indicates confidence in a 331% upside potential for the stock. Oppenheimer says this trio of penny stocks offers plenty of growth opportunity for investors. SWK Black&Decker bullish Just take a look at • Read More »